Peptide Database

Browse Research Peptides

Comprehensive profiles for 105+ peptides — dosing protocols, mechanisms of action, clinical research, and safety data.

105

Peptides

9

Categories

105 peptides · page 2 of 5

Weight LossFDA Approved

Dulaglutide

Trulicity

An FDA-approved weekly GLP-1 receptor agonist for type 2 diabetes. Fused to an Fc antibody fragment for extended duration (~5 day half-life).

FDA Approved1.5-4.5 mg weekly
ImmuneFDA Approved

Enfuvirtide

Fuzeon

A 36-amino acid peptide functioning as an HIV fusion inhibitor that prevents viral entry into cells. The first approved drug in its class.

FDA Approved90 mg subcutaneous twice daily
BioregulatorNot FDA Approved

Epithalon

Epitalon

A tetrapeptide studied for its effects on telomerase activation and potential anti-aging properties.

Clinical Trials5-10 mg daily for 10-20 days
HormonalFDA Approved

Eptifibatide

Integrilin

A cyclic peptide that inhibits platelet aggregation. Used during coronary interventions to prevent clot formation. Derived from a protein in pygmy rattlesnake venom.

FDA Approved180 mcg/kg IV bolus; 2 mcg/kg/min infusion
Weight LossFDA Approved

Exenatide

Byetta

The first GLP-1 receptor agonist approved for diabetes. Derived from Gila monster saliva. 53% homology with human GLP-1.

FDA Approved5-10 mcg twice daily or 2 mg weekly
Anti-AgingPreclinical

FOXO4-DRI

FOX04-DRI

A senolytic peptide designed to selectively eliminate senescent cells by disrupting the FOXO4-p53 interaction. Shows promise for restoring tissue function in aging.

Animal Studies2-10 mg every other day for 3 doses (one cycle)
HormonalNot FDA Approved

Follistatin

FST

A naturally occurring protein that inhibits myostatin. Studied for muscle growth and dystrophy conditions.

Clinical Trials100-300 mcg daily
CognitiveNot FDA Approved

GB-115

Ranquilon

A dipeptide anxiolytic and nootropic that acts as a CCK-1 (cholecystokinin) receptor antagonist. Effects noted by day 7.

Clinical Trials6 mg daily (2 mg three times daily)
Skin & HairNot FDA Approved

GHK-Cu

Copper Peptide

A naturally occurring copper-binding peptide found in human plasma, saliva, and urine. Widely used in skincare for its wound healing and anti-aging properties.

Clinical Trials1-2 mg daily (injection) or 0.05% topical
Growth HormoneNot FDA Approved

GHRP-2

Growth Hormone Releasing Peptide 2

A synthetic hexapeptide that acts on ghrelin receptors to stimulate GH release from the pituitary. Has the strongest GH-releasing effect among GHRPs.

Clinical Trials100-300 mcg per injection
Growth HormonePreclinical

GHRP-6

Growth Hormone Releasing Peptide 6

One of the first synthetic GH secretagogues developed. Strongly stimulates GH release and significantly increases appetite.

Clinical Trials100-300 mcg, 2-3x daily
Skin & HairPreclinical

Glow Protocol

Glow Stack

Multi-peptide blend designed for anti-aging, skin rejuvenation, collagen production, and cellular regeneration through combined tissue repair mechanisms.

Animal StudiesStandard vial: BPC-157 (5mg), TB-500 (10mg), GHK-Cu (27mg)
HormonalFDA Approved

Glucagon

GlucaGen

Life-saving treatment for severe hypoglycemia since the 1960s. Newer formulations include nasal spray (Baqsimi) and stable liquid (Gvoke).

FDA Approved1 mg IM/SC/IV or 3 mg intranasal (Baqsimi)
Anti-AgingNot FDA Approved

Glutathione

L-Glutathione

The body's master antioxidant - a tripeptide composed of glutamate, cysteine, and glycine.

Clinical Trials500-1000 mg daily (oral or liposomal)
HormonalFDA Approved

Gonadorelin

GnRH

A synthetic version of gonadotropin-releasing hormone used diagnostically and therapeutically for reproductive conditions.

FDA Approved100-500 mcg
Weight LossNot FDA Approved

HGH Fragment 176-191

Frag 176-191

The lipolytic fragment of human growth hormone. Contains the fat-burning portion of HGH without effects on blood sugar or cell proliferation.

Clinical Trials250-500 mcg daily
Growth HormoneIn Clinical Trials

Hexarelin

Examorelin

A synthetic hexapeptide GH secretagogue with the strongest GH-releasing effect among GHRPs. Also has notable cardioprotective properties independent of GH release.

Clinical Trials100-200 mcg per injection
Anti-AgingPreclinical

Humanin

HN

A mitochondria-derived peptide discovered for its neuroprotective effects against Alzheimer's-related toxicity.

Animal Studies5-10 mg weekly divided into 2-3 injections
HormonalFDA Approved

Insulin

Regular Insulin

The essential peptide hormone for glucose metabolism. Multiple formulations from rapid to long-acting available for diabetes management.

FDA ApprovedVariable by type and individual
Growth HormoneIn Clinical Trials

Ipamorelin

IPAM

A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin.

Clinical Trials200-300 mcg, 2-3x daily
HealingPreclinical

KLOW Blend

KLOW Stack

An advanced multi-peptide blend described as evolution of the Glow stack with added KPV for enhanced anti-inflammatory and gut health benefits.

Animal Studies80mg total vial: GHK-Cu (50mg), KPV (10mg), BPC-157 (10mg), TB-500 (10mg)
ImmunePreclinical

KPV

Lys-Pro-Val

A tripeptide derived from alpha-melanocyte stimulating hormone (α-MSH). Known for potent anti-inflammatory effects, particularly in the gut.

Animal Studies200-500 mcg daily
HormonalIn Clinical Trials

Kisspeptin

Kisspeptin-10

A neuropeptide that plays a critical role in initiating puberty and regulating the reproductive hormone axis.

Clinical Trials100-200 mcg subcutaneously once daily
ImmuneIn Clinical Trials

LL-37

Cathelicidin

A naturally occurring antimicrobial peptide and the only human cathelicidin. Part of the innate immune system with broad-spectrum antimicrobial activity.

Clinical Trials100-200 mcg daily